Epigenomics Management
Management criteria checks 4/4
Epigenomics' CEO is Greg Hamilton, appointed in Jul 2016, has a tenure of 6.67 years. total yearly compensation is €801.62K, comprised of 42.5% salary and 57.5% bonuses, including company stock and options. directly owns 0.016% of the company’s shares, worth $450.06. The average tenure of the management team and the board of directors is 4 years and 3.3 years respectively.
Key information
Greg Hamilton
Chief executive officer
€801.6k
Total compensation
| CEO salary percentage | 42.5% |
| CEO tenure | 6.7yrs |
| CEO ownership | 0.02% |
| Management average tenure | 4yrs |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2022 | n/a | n/a | -€7m |
| Jun 30 2022 | n/a | n/a | -€3m |
| Mar 31 2022 | n/a | n/a | -€4m |
| Dec 31 2021 | €802k | €341k | -€2m |
| Sep 30 2021 | n/a | n/a | -€3m |
| Jun 30 2021 | n/a | n/a | -€9m |
| Mar 31 2021 | n/a | n/a | -€10m |
| Dec 31 2020 | €806k | €349k | -€12m |
| Sep 30 2020 | n/a | n/a | -€16m |
| Jun 30 2020 | n/a | n/a | -€16m |
| Mar 31 2020 | n/a | n/a | -€17m |
| Dec 31 2019 | €878k | €385k | -€17m |
| Sep 30 2019 | n/a | n/a | -€14m |
| Jun 30 2019 | n/a | n/a | -€14m |
| Mar 31 2019 | n/a | n/a | -€12m |
| Dec 31 2018 | €962k | €349k | -€13m |
| Sep 30 2018 | n/a | n/a | -€11m |
| Jun 30 2018 | n/a | n/a | -€10m |
| Mar 31 2018 | n/a | n/a | -€11m |
| Dec 31 2017 | €909k | €353k | -€10m |
| Sep 30 2017 | n/a | n/a | -€9m |
| Jun 30 2017 | n/a | n/a | -€10m |
| Mar 31 2017 | n/a | n/a | -€9m |
| Dec 31 2016 | €433k | €183k | -€11m |
Compensation vs Market: Greg's total compensation ($USD869.53K) is about average for companies of similar size in the US market ($USD740.57K).
Compensation vs Earnings: Greg's compensation has been consistent with company performance over the past year.
CEO
Greg Hamilton (52 yo)
6.7yrs
Tenure
€801,616
Compensation
Mr. Gregory K. Hamilton, also known as Greg, has been the Chief Executive Officer and Member of Executive Board at Epigenomics AG since July 1, 2016. Mr. Hamilton has over 20 years of management experience...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Member of the Executive Board | 6.7yrs | €801.62k | 0.016% € 450.1 | |
| President & Chief Scientific Officer | 1.3yrs | €370.14k | no data | |
| CFO & Member of Executive Board | 1.1yrs | no data | no data | |
| Investor Relations Officer | no data | no data | no data | |
| Chief Executive Officer of Epigenomics Inc. | 11.8yrs | no data | no data |
4.0yrs
Average Tenure
52yo
Average Age
Experienced Management: EPGN.Y's management team is considered experienced (4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Member of Supervisory Board | less than a year | no data | no data | |
| Chairman of the Supervisory Board | 6.8yrs | €28.38k | 0.013% € 371.5 | |
| Member of the Supervisory Board | 3.8yrs | €28.38k | 0.015% € 412.9 | |
| Vice-chairman of Supervisory Board | 2.8yrs | €26.54k | 0.070% € 1.9k |
3.3yrs
Average Tenure
51.5yo
Average Age
Experienced Board: EPGN.Y's board of directors are considered experienced (3.3 years average tenure).